Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 1;63(suppl 4):S236-S243.
doi: 10.1093/cid/ciw559.

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

Gayatri Amirthalingam  1 , Helen Campbell  1 , Sonia Ribeiro  1 , Norman K Fry  2 , Mary Ramsay  1 , Elizabeth Miller  1 , Nick Andrews  3
Affiliations

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

Gayatri Amirthalingam et al. Clin Infect Dis. .

Abstract

The effectiveness of maternal immunization in preventing infant pertussis was first demonstrated in England, 1 year after the program using diphtheria-tetanus-5-component acellular pertussis-inactivated polio vaccine (dT5aP-IPV) was introduced in 2012. Vaccine effectiveness against laboratory-confirmed pertussis has been sustained >90% in the 3 years following its introduction, despite changing to another acellular vaccine with different antigen composition. Consistent with this, disease incidence in infants <3 months of age has remained low despite high activity persisting in those aged 1 year and older. Vaccine effectiveness against infant deaths was estimated at 95% (95% confidence interval, 79%-100%). Additional protection from maternal immunization is retained in infants who received their first dose of the primary series. There is no longer evidence of additional protection from maternal vaccination after the third infant dose. Although numbers are small and ongoing assessment is required, there is no evidence of increased risk of disease after primary immunization in infants whose mothers received maternal vaccination.

Keywords: maternal pertussis vaccination; vaccine effectiveness.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Maternal pertussis vaccine coverage, England, October 2012–August 2013, Clinical Practice Research Datalink (CPRD) and Immform. Denominator for CPRD is number of women delivering a live infant, by week of birth; denominator for Immform is number of pregnant women with an estimated date of delivery, each month. Abbreviations: dT3aP, diphtheria–tetanus–3-component acellular pertussis vaccine; dT5aP, diphtheria–tetanus–5-component acellular pertussis vaccine; IPV, inactivated polio vaccine.
Figure 2.
Figure 2.
Incidence of laboratory-confirmed pertussis, by year and age group, England only, 1998–2015.
See this image and copyright information in PMC

References

    1. World Health Organization. Revised guidance on the choice of pertussis vaccines: July 2014. Wkly Epidemiol Rec 2014; 89:337–40. - PubMed
    1. Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation: minutes of meeting held October 2012. Available at: https://app.box.com/s/iddfb4ppwkmtjusir2tc#/s/iddfb4ppwkmtjusir2tc/1/219.... Accessed 27 June 2016.
    1. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131–5. - PMC - PubMed
    1. Australian Government Department of Health. The Australian Immunisation Handbook. 10th ed, 2015. Available at: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Conte.... Accessed 27 June 2016.
    1. Vizzotti C, Neyro S, Katz N et al. . Maternal immunization in Argentina: a storyline from the prospective of a middle income country. Vaccine 2015; 33:6413–9. - PubMed

Substances